Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
AZD-3463: Structural Insights and Assay Impact in ALK/IGF1R
2026-05-29
Explore how the ALK/IGF1R inhibitor AZD3463 uniquely advances neuroblastoma research through a structural lens, with a focus on practical assay design and kinase selectivity. This article delivers deep scientific context and actionable guidance for translational cancer studies.
-
Z-VAD-FMK: Unraveling Apoptosis Inhibition and Cell Death In
2026-05-29
Explore the multifaceted role of Z-VAD-FMK in apoptosis inhibition and its unique impact on dissecting regulated cell death pathways. This in-depth article provides advanced insights for researchers using Z-VAD-FMK in apoptotic and ferroptotic studies, highlighting innovations that set it apart.
-
Oligo (dT) 25 Beads: Technical Guide for mRNA Purification
2026-05-28
Oligo (dT) 25 Beads address the challenge of isolating high-quality eukaryotic mRNA from total RNA or cellular lysates, enabling reliable downstream applications such as cDNA synthesis and RT-PCR. They are well-suited for workflows requiring selective capture of polyadenylated transcripts, but are not recommended for non-polyadenylated RNA species or single-cell sensitivity requirements.
-
Apicidin Impairs Oocyte Maturation by Disrupting Meiotic App
2026-05-28
The reference study demonstrates that Apicidin, a mycotoxin and potent histone deacetylase inhibitor, disrupts oocyte meiotic maturation by impairing spindle assembly and altering histone acetylation. These findings deepen our understanding of the reproductive toxicity of emerging mycotoxins and highlight critical epigenetic vulnerabilities in oocyte development.
-
Sodium Orthovanadate: Precision in Phosphorylation State Pre
2026-05-27
Sodium Orthovanadate (Na3VO4) is the gold-standard inhibitor for preserving tyrosine phosphorylation during cell signaling and kinase assays. This article delivers actionable workflow enhancements, troubleshooting tips, and cross-study insights to maximize reproducibility and data fidelity in phosphorylation-dependent research.
-
Mianserin HCl: Advanced 5-HT2 Receptor Antagonist Workflows
2026-05-27
Mianserin HCl stands out as a versatile 5-HT2 receptor antagonist for psychiatric, metabolic, and antipathogenic research. This guide delivers stepwise experimental protocols, troubleshooting tactics, and actionable insights from recent cyclodextrin-complexation studies to optimize assay outcomes.
-
Advances in In Vitro Drug Response Assessment for Cancer Res
2026-05-26
Schwartz's dissertation introduces a refined approach to evaluating anticancer drug responses in vitro by distinguishing between proliferative arrest and cell death, addressing a critical gap in standard drug evaluation methods. This work holds practical implications for improving preclinical assessment and translational relevance of novel agents, including PARP inhibitors used in breast cancer research.
-
Praeruptorin A Suppresses NF-κB and Inflammation in Poly (I:
2026-05-26
This study elucidates how Praeruptorin A, a natural coumarin, inhibits key inflammatory pathways in poly (I:C)-stimulated RAW264.7 macrophages. By demonstrating suppression of NF-κB activation and pro-inflammatory gene expression, the work advances mechanistic understanding of inflammation modulation in viral-mimetic models, with implications for anti-inflammatory drug discovery.
-
Zolmitriptan: Bridging Migraine Mechanisms and Lysosomal Bio
2026-05-25
This thought-leadership article explores Zolmitriptan as a 5-HT1B receptor agonist at the intersection of migraine pathophysiology and emerging lysosomal biology. It offers advanced mechanistic insights, actionable guidance for translational researchers, and a critical evaluation of new cross-domain research frontiers, setting a new standard for scientific strategy in serotonin receptor pharmacology.
-
SARS-CoV-2 N Protein Disrupts GADD34-Driven Antiviral Immuni
2026-05-25
This study reveals how the SARS-CoV-2 nucleocapsid protein impairs host innate immunity by sequestering GADD34 mRNA into atypical stress granule-like foci. These findings elucidate a novel mechanism of viral immune evasion and suggest new targets for antiviral intervention.
-
P2RX1 Drives Mitochondrial Apoptosis in Ph+ ALL via CaMKII/P
2026-05-24
This study provides novel mechanistic insight into how P2RX1 overexpression promotes mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) cells via calcium-mediated CaMKII activation and suppression of PI3K/Akt signaling. These findings highlight a potential therapeutic target for overcoming tyrosine kinase inhibitor resistance and improving outcomes in Ph+ ALL.
-
AptaBLE: Deep Learning for Aptamer-Protein Binding Predictio
2026-05-23
AptaBLE introduces a deep learning architecture for the accurate prediction and de novo generation of aptamers that bind proteins with high specificity. By overcoming key limitations of SELEX and previous computational methods, this platform enables more efficient discovery of aptamers for therapeutic and diagnostic use.
-
Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera
2026-05-22
The referenced study details the rational design and biological evaluation of novel allosteric inhibitors targeting pyruvate dehydrogenase kinase 4 (PDK4), a key regulator implicated in metabolic disorders. By identifying compound 8c with potent in vitro and in vivo activity, the research provides a valuable scaffold for developing new treatments for diabetes, obesity, allergic disease, and cancer.
-
Ellagic Acid (A2306): Unveiling CK2 Inhibition in Senescence
2026-05-22
Explore Ellagic acid as a selective CK2 inhibitor for advanced cancer biology and oxidative stress research. This article uniquely bridges mechanistic insight with practical assay considerations, offering a fresh perspective on senescence-targeted discovery.
-
TMRE Mitochondrial Membrane Potential Assay Kit: Precision i
2026-05-21
The TMRE mitochondrial Membrane Potential Assay Kit empowers researchers to sensitively quantify mitochondrial health and apoptosis with unparalleled reproducibility. Its Tetramethylrhodamine ethyl ester mitochondrial probe, flexible workflow, and built-in controls streamline high-throughput studies in cellular metabolism and disease modeling.